Hematox vs ASTCT Practice Guidelines

Hematox®, a bibliographical databank based on drug-induced blood disorders, was created in 1983 by Michel BIOUR (MD, PhD), and monthly updated in accordance with other bibliographical databases to the analysis of the references cited in the articles. All the published cases for selection and classification were re-evaluated in accordance with criterions usually validated in hematology. 1069 drugs are registered with 15126 corresponding and available references. Anticancer drugs and immunomodulators, well known for their intrinsic hematotoxicity, are not indexed in Hematox.

ASTCT practice guidelines and clinical calculators for blood and bone marrow transplantation, and cellular therapies. The ASTCT Practice Guidelines application provides up to date access to practice guidelines, evidence-based reviews and position statements from the ASTCT Committee on Practice Guidelines. These documents are developed and updated by leading experts in the field of blood and bone marrow transplantation and cellular therapy. In addition the app includes clinical calculators relevant to HCT patients. These tools will allow immediate access to information that can help guide clinical decision making. Topics covered include: • General guidelines • Conditioning regimens • Stem cell collection and mobilization • Graft-Versus-Host disease • HCT for Malignant and non-Malignant Hematologic Diseases, including pediatric and adult patients • Supportive Care • Survivorship Detailed references and full access to source papers is also provided. The American Society for Transplantation and Cellular Therapy (ASTCT) is an international professional membership association of physicians, investigators and other health care professionals, dedicated to improving the application and success of blood and marrow transplantation and related cellular therapies.